The use of functional placental magnetic resonance imaging for assessment of the placenta after prolonged preterm rupture of the membranes in vivo: A pilot study.
chorioamnionitis
histopathology
inflammation
magnetic resonance imaging
placenta
preterm birth
preterm prelabor rupture of membranes
Journal
Acta obstetricia et gynecologica Scandinavica
ISSN: 1600-0412
Titre abrégé: Acta Obstet Gynecol Scand
Pays: United States
ID NLM: 0370343
Informations de publication
Date de publication:
Dec 2021
Dec 2021
Historique:
revised:
18
08
2021
received:
21
05
2021
accepted:
31
08
2021
pubmed:
22
9
2021
medline:
15
12
2021
entrez:
21
9
2021
Statut:
ppublish
Résumé
Preterm prelabor rupture of membranes (PPROM) complicates 3% of pregnancies in the UK. Where delivery does not occur spontaneously, expectant management until 37 weeks of gestation is advocated, unless signs of maternal infection develop. However, clinical presentation of maternal infection can be a late sign and injurious fetal inflammatory responses may already have been activated. There is therefore a need for more sensitive markers to aid optimal timing of interventions. At present there is no non-invasive test in clinical practice to assess for infection in the fetal compartment and definitive diagnosis of chorioamnionitis is by histological assessment of the placenta after delivery. This study presents comprehensive functional placental magnetic resonance imaging (MRI) quantification, already used in other organ systems, to assess for infection/inflammation, in women with and without PPROM aiming to explore its use as a biomarker for inflammation within the feto-placental compartment in vivo. Placental MRI scans were performed in a cohort of 12 women (with one having two scans) with PPROM before 34 weeks of gestation (selected because of their high risk of infection), and in a control group of 87 women. Functional placental assessment was performed with magnetic resonance techniques sensitive to changes in the microstructure (diffusion) and tissue composition (relaxometry), with quantification performed both over the entire organ and in regions of interest between the basal and chorionic plate. Placental histology was analyzed after delivery where available. Normative evolution of functional magnetic resonance biomarkers over gestation was studied. Cases of inflammation, as assessed by histological presence of chorioamnionitis, and umbilical cord vasculitis with or without funisitis, were associated with lower T2* (mean T2* at 30 weeks 50 ms compared with 58 ms in controls) and higher fractional anisotropy (mean at 30 weeks 0.55 compared with 0.45 in controls). These differences did not reach significance and there was substantial heterogeneity both in T2* and Apparent Diffusivitiy across the cohort. This first exploration of functional placental assessment in a cohort of women with PPROM demonstrates that functional placental MRI can reveal a range of placental changes associated with inflammatory processes. It is a promising tool to gain information and in the future to identify inflammation in vivo, and could therefore assist in improving optimal timing for interventions designed to prevent fetal injury.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2244-2252Subventions
Organisme : UK Research and Innovation Future Leaders Fellowship
ID : MR/T018119/1
Organisme : Medical Research Council
ID : MR/T018119/1
Pays : United Kingdom
Organisme : NIH Human Placenta Project
ID : 1U01HD087202-01
Organisme : Sir Henry Wellcome Fellowship
ID : 201374/Z/16/Z
Organisme : King's Health Partners
Organisme : National Institute of Child Health and Human Development
Informations de copyright
© 2021 The Authors. Acta Obstetricia et Gynecologica Scandinavica published by John Wiley & Sons Ltd on behalf of Nordic Federation of Societies of Obstetrics and Gynecology (NFOG).
Références
National Collaborating Centre for Women's and Children's Health (UK). Preterm Labour and Birth. National Institute for Health and Care Excellence (UK); 2015.
Nasef N, Shabaan AE, Schurr P, et al. Effect of clinical and histological chorioamnionitis on the outcome of preterm infants. Am J Perinatol. 2013;30:59-68.
Mangham LJ, Petrou S, Doyle LW, Draper ES, Marlow N. The cost of preterm birth throughout childhood in England and Wales. Pediatrics. 2009;123:e312-e327.
Mercer BM. Preterm premature rupture of the membranes. Obstet Gynecol. 2003;101:178-193.
Thomas W, Speer CP. Chorioamnionitis: important risk factor or innocent bystander for neonatal outcome? Neonatology. 2011;99:177-187.
Morris JM, Roberts CL, Bowen JPJ, et al. Immediate delivery compared with expectant management after preterm pre-labour rupture of the membranes close to term (PPROMT trial): a randomised controlled trial. Lancet. 2016;387:444-452.
Peaceman AM, Lai Y, Rouse DJ, et al. Length of latency with preterm premature rupture of membranes before 32 weeks’ gestation. Am J Perinatol. 2015;32:57-62.
Thomson AJ. Royal College of Obstetricians and Gynaecologists. Care of women presenting with suspected preterm prelabour rupture of membranes from 24+0 weeks of gestation. BJOG. 2019;126:e152-e166.
Blackwell SC, Berry SM. Role of amniocentesis for the diagnosis of subclinical intra-amniotic infection in preterm premature rupture of the membranes. Curr Opin Obstet Gynecol. 1999;11:541-5477.
Ramsey PS, Lieman JM, Brumfield CG, et al. Chorioamnionitis increases neonatal morbidity in pregnancies complicated by preterm premature rupture of membranes. Am J Obstet Gynecol. 2005;192:1162-1166.
Merenstein GB, Weisman LE. Premature rupture of the membranes: neonatal consequences. Semin Perinatol. 1996;20:375-380.
Kamdar S, Hutchinson R, Laing A, et al. Perinatal inflammation influences but does not arrest rapid immune development in preterm babies. Nat Commun. 2020;11:1284.
Gee MS, Harisinghani MG. MRI in patients with inflammatory bowel disease. J Magn Reson Imaging. 2011;33:527-534.
Pouillon L, Laurent V, Pouillon M, et al. Diffusion-weighted MRI, Lancet. Gastroenterol Hepatol. 2018;3:433-443.
Bohnen S, Radunski UK, Lund GK, et al. Tissue characterization by T1 and T2 mapping cardiovascular magnetic resonance imaging to monitor myocardial inflammation in healing myocarditis. Eur Heart J Cardiovasc Imaging. 2017;18:744-751.
Sørensen A, Peters D, Fründ E, Lingman G, Christiansen O, Uldbjerg N. Changes in human placental oxygenation during maternal hyperoxia estimated by blood oxygen level-dependent magnetic resonance imaging (BOLD MRI). Ultrasound Obstet Gynecol. 2013;42:310-314.
Ho AEP, Hutter J, Jackson LH, et al. T2* placental magnetic resonance imaging in preterm preeclampsia. An Observational Cohort Study. Hypertension. 2020;75:1523-1531.
Sinding M, Peters DA, Frøkjaer JB, et al. Placental magnetic resonance imaging T2* measurements in normal pregnancies and in those complicated by fetal growth restriction. Ultrasound Obstet Gynecol. 2016;47:748-754.
Hutter J, Slator PJ, Jackson L, et al. Multi-modalfunctional MRI to explore placental function over gestation. Magn Reson Med. 2019;81:1191-1204.
Dellschaft NS, Hutchinson G, Shah S, et al. The haemodynamics of the human placenta in utero. PLoS Biol. 2020;18:e3000676.
Melbourne A, Aughwane R, Sokolska M, et al. Separating fetal and maternal placenta circulations using multiparametric MRI. Magn Reson Med. 2019;81:350-361.
Slator PJ, Hutter J, Palombo M. Combined diffusion-relaxometry MRI to identify dysfunction in the human placenta. Magn Reson Med. 2019;82:95-106.
Redline RW. Inflammatory responses in the placenta and umbilical cord. Semin Fetal Neonatal Med. 2006;11:296-301.
Gaspar AS, Nunes RG, Ferrazzi G, et al. Optimizing maternal fat suppression with constrained image-based shimming in fetal MR. Magn Reson Med. 2019;81:477-485.
Hutter J, Jackson L, Ho A, et al. T2* relaxometry to characterize normal placental development over gestation in-vivo at 3T [version 1; peer review: 1 approved, 1 approved with reservations]. Wellcome Open Res. 2019;4:166. doi: 10.12688/wellcomeopenres.15451.1
Story L, Zhang T, Steinweg JK, et al. Foetal lung volumes in pregnant women who deliver very preterm: a pilot study. Pediatr Res. 2020;87:1066-1071.
Story L, Zhang T, Uus A, et al. Antenatal thymus volumes in fetuses that deliver <32 weeks gestation: an MRI pilot study. Acta Obstet Gynecol Scand. 2021;100:1040-1050.
Linduska N, Dekan S, Messerschmidt A, et al. Placental pathologies in fetal MRI with pathohistological correlation. Placenta. 2009;30:555-559.
Cappelletti M, Presicce P, Kallapur SG. Immunobiology of acute chorioamnionitis. Front Immunol. 2020;11:649.
Arias F, Victoria A, Cho K, Kraus F. Placental histology and clinical characteristics of patients with preterm premature rupture of membranes. Obstet Gynecol. 1997;89:265-271.
Morgan TK. Role of the placenta in preterm birth: a review. Am J Perinatol. 2016;33:258-266.
Kim CJ, Romero R, Chaemsaithong P, Kim JS. Chronic inflammation of the placenta: definition, classification, pathogenesis, and clinical significance. Am J Obstet Gynecol. 2015;213:S53-S69.
Uus A, Steinweg JK, Ho A, et al. Deformable slice-to-volume registration for reconstruction of quantitative T2* placental and fetal MRI. In: Hu Y, et al. (Eds) Medical Ultrasound, and Preterm, Perinatal and Paediatric Image Analysis. 2020, ASMUS 2020, PIPPI 2020. Lecture Notes in Computer Science, Vol. 12437. Springer. 10.1007/978-3-030-60334-2_22
Abulnaga SM, Turk EA, Bessmeltsev M, Grant PE, Solomon J, Golland P. Placental flattening via volumetric parameterization. Med Image Comput Comput Assist Interv. 2019;11767:39-47.
Miao G, Mistelbauer A, Karimov A, et al. Placenta maps: in utero placental health assessment of the human fetus. IEEE Trans Vis Comput Graph. 2017;23:1612-1623.
van der Krogt L, Ridout AE, Seed PT, Shennan AH. Placental inflammation and its relationship to cervicovaginal fetal fibronectin in preterm birth. Eur J Obstet Gynecol Reprod Biol. 2017;214:173-177.
Korzeniewski SJ, Romero R, Chaiworapongsa T, et al. Maternal plasma angiogenic index-1 (placental growth factor/soluble vascular endothelial growth factor receptor-1) is a biomarker for the burden of placental lesions consistent with uteroplacental underperfusion: a longitudinal case-cohort study. Am J Obstet Gynecol. 2016;214(5):629.e1-629.e17.